These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 28915335)

  • 1. ECM-Related Myopathies and Muscular Dystrophies: Pros and Cons of Protein Therapies.
    Van Ry PM; Fontelonga TM; Barraza-Flores P; Sarathy A; Nunes AM; Burkin DJ
    Compr Physiol; 2017 Sep; 7(4):1519-1536. PubMed ID: 28915335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From Mice to Humans: An Overview of the Potentials and Limitations of Current Transgenic Mouse Models of Major Muscular Dystrophies and Congenital Myopathies.
    Sztretye M; Szabó L; Dobrosi N; Fodor J; Szentesi P; Almássy J; Magyar ZÉ; Dienes B; Csernoch L
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular matrix-driven congenital muscular dystrophies.
    Mohassel P; Foley AR; Bönnemann CG
    Matrix Biol; 2018 Oct; 71-72():188-204. PubMed ID: 29933045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The childhood muscular dystrophies: making order out of chaos.
    Tsao CY; Mendell JR
    Semin Neurol; 1999; 19(1):9-23. PubMed ID: 10711985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [CRISPR-Cas9 for muscle dystrophies].
    Ballouhey O; Bartoli M; Levy N
    Med Sci (Paris); 2020 Apr; 36(4):358-366. PubMed ID: 32356712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inherited myopathies and muscular dystrophies.
    Cardamone M; Darras BT; Ryan MM
    Semin Neurol; 2008 Apr; 28(2):250-9. PubMed ID: 18351526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of an ultrasound-mediated nucleic acid delivery system for treating muscular dystrophies].
    Negishi Y; Hamano N; Shiono H; Akiyama S; Endo-Takahashi Y; Suzuki R; Maruyama K; Aramaki Y
    Yakugaku Zasshi; 2012; 132(12):1383-8. PubMed ID: 23208045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Congenital myopathies/dystrophies.
    Riggs JE; Bodensteiner JB; Schochet SS
    Neurol Clin; 2003 Nov; 21(4):779-94; v-vi. PubMed ID: 14743649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscle diseases: the muscular dystrophies.
    McNally EM; Pytel P
    Annu Rev Pathol; 2007; 2():87-109. PubMed ID: 18039094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic approaches to muscular dystrophy.
    Goyenvalle A; Seto JT; Davies KE; Chamberlain J
    Hum Mol Genet; 2011 Apr; 20(R1):R69-78. PubMed ID: 21436158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy in large animal models of muscular dystrophy.
    Wang Z; Chamberlain JS; Tapscott SJ; Storb R
    ILAR J; 2009; 50(2):187-98. PubMed ID: 19293461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stem cell therapies to treat muscular dystrophy: progress to date.
    Meregalli M; Farini A; Parolini D; Maciotta S; Torrente Y
    BioDrugs; 2010 Aug; 24(4):237-47. PubMed ID: 20623990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perspectives on hiPSC-Derived Muscle Cells as Drug Discovery Models for Muscular Dystrophies.
    Abati E; Sclarandi E; Comi GP; Parente V; Corti S
    Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging strategies for cell and gene therapy of the muscular dystrophies.
    Muir LA; Chamberlain JS
    Expert Rev Mol Med; 2009 Jun; 11():e18. PubMed ID: 19555515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy for muscular dystrophy: moving the field forward.
    Al-Zaidy S; Rodino-Klapac L; Mendell JR
    Pediatr Neurol; 2014 Nov; 51(5):607-18. PubMed ID: 25439576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscular dystrophies: histology, immunohistochemistry, molecular genetics and management.
    Costanza L; Moggio M
    Curr Pharm Des; 2010; 16(8):978-87. PubMed ID: 20041828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome- and Cell-Based Strategies in Therapy of Muscular Dystrophies.
    Saada YB; Dib C; Lipinski M; Vassetzky YS
    Biochemistry (Mosc); 2016 Jul; 81(7):678-90. PubMed ID: 27449614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscular dystrophy: from pathogenesis to strategy.
    Hsu YD
    Acta Neurol Taiwan; 2004 Jun; 13(2):50-8. PubMed ID: 15478675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The up-regulation of utrophin is not limited to muscular dystrophies.
    Lukás Z
    Gen Physiol Biophys; 1999 Dec; 18 Suppl 1():87-9. PubMed ID: 10707847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy in monogenic congenital myopathies.
    Guan X; Goddard MA; Mack DL; Childers MK
    Methods; 2016 Apr; 99():91-8. PubMed ID: 26454198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.